Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Apr
10
Today In Oncology
How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs
Japanese Study Looks at Rates of Cancer Therapy–Related AML
Researchers Identify Blood-Based Biomarker for Cancer Risk in People With Lynch Syndrome
Final Report on Pralsetinib in Advanced RET Fusion–Positive NSCLC
New ASH HematOmics Program Offers Blood Cancer Data Integration Tool to Accelerate Research
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo